Structures by: Thorat S. H.
Total: 38
C22H24N3O4,C12H10ClN2O5S
C22H24N3O4,C12H10ClN2O5S
CrystEngComm (2020)
a=15.3649(5)Å b=10.2088(4)Å c=23.5463(8)Å
α=90° β=106.752(2)° γ=90°
Gefitinib-mefenamic acid cocrystal
C22H24ClFN4O3,C15H15N1O2,H2O
CrystEngComm (2020)
a=10.9083(7)Å b=7.6817(5)Å c=41.588(3)Å
α=90° β=96.132(4)° γ=90°
C27H33BrN4O5S
C27H33BrN4O5S
Organic & biomolecular chemistry (2015) 13, 10 3064-3069
a=6.7186(2)Å b=15.8096(5)Å c=26.5176(7)Å
α=90.00° β=90.00° γ=90.00°
C21H32N4O6S2
C21H32N4O6S2
Organic & biomolecular chemistry (2015) 13, 10 3064-3069
a=18.6244(11)Å b=8.4267(4)Å c=16.0611(8)Å
α=90.00° β=93.118(5)° γ=90.00°
C23H27BrN4O6S2
C23H27BrN4O6S2
Organic & biomolecular chemistry (2015) 13, 10 3064-3069
a=8.1060(12)Å b=10.5928(16)Å c=14.983(2)Å
α=90.00° β=96.273(8)° γ=90.00°
C17H26N4O6S2
C17H26N4O6S2
Organic & biomolecular chemistry (2015) 13, 10 3064-3069
a=9.5896(2)Å b=14.7665(3)Å c=14.7848(3)Å
α=90.00° β=90.00° γ=90.00°
C19H20BrN3O4S
C19H20BrN3O4S
Organic & biomolecular chemistry (2015) 13, 10 3064-3069
a=9.2942(10)Å b=13.9119(13)Å c=15.3096(17)Å
α=90.00° β=90.00° γ=90.00°
C14H20N2O5S
C14H20N2O5S
Organic & biomolecular chemistry (2015) 13, 10 3064-3069
a=7.1146(3)Å b=8.0387(3)Å c=15.0865(6)Å
α=90.323(2)° β=100.054(2)° γ=109.252(2)°
C25H30N2O3S
C25H30N2O3S
Chemical communications (Cambridge, England) (2016) 52, 92 13475-13478
a=15.6911(13)Å b=7.8759(7)Å c=19.8219(14)Å
α=90° β=106.907(2)° γ=90°
C16H21NO5S
C16H21NO5S
New Journal of Chemistry (2018) 42, 2 1078
a=31.2006(17)Å b=10.1101(5)Å c=5.9607(4)Å
α=90° β=93.505(4)° γ=90°
C10H9Cl2NO2S
C10H9Cl2NO2S
New Journal of Chemistry (2018) 42, 2 1078
a=6.9790(7)Å b=8.4645(9)Å c=19.895(2)Å
α=90° β=90° γ=90°
C15H18N2O6S
C15H18N2O6S
New Journal of Chemistry (2018) 42, 2 1078
a=10.0776(4)Å b=6.3731(3)Å c=13.2240(6)Å
α=90° β=90.4180(10)° γ=90°
C15H17Cl2NO4S
C15H17Cl2NO4S
New Journal of Chemistry (2018) 42, 2 1078
a=9.4352(11)Å b=10.4526(12)Å c=18.336(2)Å
α=90° β=90° γ=90°
C15H19NO5S
C15H19NO5S
New Journal of Chemistry (2018) 42, 2 1078
a=22.5029(5)Å b=22.5029(5)Å c=6.4423(2)Å
α=90° β=90° γ=90°
C7H7IN2O
C7H7IN2O
CrystEngComm (2016) 18, 37 7078
a=11.8183(6)Å b=7.9251(4)Å c=8.9570(5)Å
α=90° β=90.047(3)° γ=90°
C7H7IN2O
C7H7IN2O
CrystEngComm (2016) 18, 37 7078
a=21.4515(4)Å b=8.44460(10)Å c=8.99770(10)Å
α=90° β=90° γ=90°
C7H7IN2O
C7H7IN2O
CrystEngComm (2016) 18, 37 7078
a=4.6211(7)Å b=5.2775(8)Å c=16.932(3)Å
α=90° β=96.344(2)° γ=90°
C13H11IN2S
C13H11IN2S
CrystEngComm (2016) 18, 37 7078
a=12.7772(11)Å b=5.1405(4)Å c=20.7792(16)Å
α=90.00° β=99.085(5)° γ=90.00°
C13H11IN2O
C13H11IN2O
CrystEngComm (2016) 18, 37 7078
a=21.0485(13)Å b=4.6303(3)Å c=12.8294(7)Å
α=90° β=102.835(4)° γ=90°
C13H11IN2S
C13H11IN2S
CrystEngComm (2016) 18, 37 7078
a=12.6626(17)Å b=7.0591(10)Å c=15.395(2)Å
α=90° β=94.006(2)° γ=90°
C13H10FIN2O
C13H10FIN2O
CrystEngComm (2016) 18, 37 7078
a=27.607(6)Å b=4.6224(11)Å c=9.750(2)Å
α=90° β=93.235(3)° γ=90°
C14H13IN2OS
C14H13IN2OS
CrystEngComm (2016) 18, 37 7078
a=12.481(2)Å b=9.9446(16)Å c=23.867(4)Å
α=90° β=96.736(2)° γ=90°
C14H13IN2OS
C14H13IN2OS
CrystEngComm (2016) 18, 37 7078
a=8.1518(6)Å b=18.2688(13)Å c=9.5334(7)Å
α=90° β=93.6720(10)° γ=90°
C13H10IN3O2S
C13H10IN3O2S
CrystEngComm (2016) 18, 37 7078
a=14.2167(19)Å b=14.5308(18)Å c=6.8955(10)Å
α=90.00° β=90.00° γ=90.00°
C13H11IN2S
C13H11IN2S
CrystEngComm (2016) 18, 37 7078
a=15.3895(12)Å b=5.4985(5)Å c=17.1612(15)Å
α=90° β=116.180(4)° γ=90°
C13H11IN2O
C13H11IN2O
CrystEngComm (2016) 18, 37 7078
a=26.1800(17)Å b=4.6273(3)Å c=9.9779(7)Å
α=90.00° β=91.646(3)° γ=90.00°
C13H11IN2O
C13H11IN2O
CrystEngComm (2016) 18, 37 7078
a=27.253(5)Å b=4.6408(9)Å c=9.8532(18)Å
α=90° β=91.991(6)° γ=90°
C17H26N4O6S2
C17H26N4O6S2
Organic & biomolecular chemistry (2015) 13, 10 3064-3069
a=7.7425(4)Å b=10.0108(6)Å c=13.8284(8)Å
α=90.00° β=102.033(3)° γ=90.00°
C21H21N3O3
C21H21N3O3
RSC Adv. (2015)
a=13.9952(17)Å b=9.1123(12)Å c=15.2436(19)Å
α=90.00° β=97.909(9)° γ=90.00°
C22H19N5O
C22H19N5O
RSC Adv. (2015)
a=12.3799(12)Å b=13.0555(12)Å c=11.5532(11)Å
α=90.00° β=98.570(5)° γ=90.00°
Iressa
C22H24ClFN4O3
CrystEngComm (2014) 16, 37 8638
a=7.1645(2)Å b=10.8025(3)Å c=14.3429(4)Å
α=80.3020(10)° β=75.6620(10)° γ=89.2670(10)°
Iressa
C22H24ClFN4O3
CrystEngComm (2014) 16, 37 8638
a=8.8091(4)Å b=9.6702(4)Å c=12.4941(5)Å
α=93.700(2)° β=97.546(2)° γ=101.939(2)°
Pyrazinamide--<i>p</i>-aminobenzoic acid (1/1)
C7H7N1O2,C5H5N3O1
Acta Crystallographica Section C (2015) 71, 11
a=7.9293(8)Å b=15.1231(16)Å c=10.2490(12)Å
α=90.00° β=100.862(6)° γ=90.00°
4-(Pyrazine-2-carboxamido)benzoic acid
C12H9N3O3
Acta Crystallographica Section C (2015) 71, 11
a=6.0535(5)Å b=7.4159(6)Å c=13.2548(10)Å
α=85.612(5)° β=81.900(5)° γ=66.398(5)°
C12H11N2O5Cl1S1,0.5(C10N2H8)
C12H11N2O5Cl1S1,0.5(C10N2H8)
Crystal Growth & Design (2015) 15, 12 5858
a=11.4746(2)Å b=9.6630(2)Å c=16.1003(3)Å
α=90° β=101.2150(10)° γ=90°
C12H11ClN2O5S,0.5(C10H8N2)
C12H11ClN2O5S,0.5(C10H8N2)
Crystal Growth & Design (2015) 15, 12 5858
a=25.981(5)Å b=6.5254(13)Å c=21.043(4)Å
α=90° β=107.372(3)° γ=90°
(C12H11ClN2O5S,C5H6N2)
(C12H11ClN2O5S,C5H6N2)
Crystal Growth & Design (2015) 15, 12 5858
a=8.5913(2)Å b=12.9773(3)Å c=17.6723(4)Å
α=84.4360(10)° β=84.9390(10)° γ=75.4550(10)°
C39H34Cl2N7O10S2
C39H34Cl2N7O10S2
Crystal Growth & Design (2015) 15, 12 5858
a=10.2035(2)Å b=14.0538(3)Å c=15.1873(3)Å
α=107.1600(10)° β=107.3050(10)° γ=91.4320(10)°